New pharmacological options in the treatment of Alzheimer's disease

被引：2
|
作者：
Kleinova, L. [1 ,2 ]
Cerman, J. [2 ]
Hlavka, J. [3 ]
Hort, J. [2 ]
机构：
[1] 1 LF UK, Vseobecne Lekarstvi, Prague, Czech Republic
[2] Neurol Klin 2 LF UK, Kognitivni Ctr, V Uvalu 84, Prague 15006, Czech Republic
[3] Univ Southern Calif, Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA USA
来源：
CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE | 2022年 / 85卷 / 06期
关键词：
Alzheimer?s disease; phase three testing  of new drugs; β -amyloid; tau protein; neuroinflammatory theory; ric symptoms; neuroprotection; BETA; TRAMIPROSATE; INHIBITION; GUANFACINE; DEMENTIA; TRIAL;
D O I：
10.48095/cccsnn2022462
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
A new era of innovative treatment options for Alzheimer's disease is emerging. New goals of treatment are being developed with various monoclonal antibodies targeting potentially pathological molecules involved in the pathogenesis of Alzheimer's disease. The aim of this review is to acquaint the reader with new potential drugs, while most of those mentioned in this review are in the third phase of clinical trials.
引用
收藏
页码：462 / 469
页数：8
相关论文
共 50 条
  • [31] Unmet Needs in Pharmacological Treatment of Apathy in Alzheimer's Disease: A Systematic Review
    Theleritis, Christos G.
    Siarkos, Kostas T.
    Politis, Antonios M.
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [32] Alzheimer's Disease: Cellular and Pharmacological Aspects
    Emiliano Aranda-Abreu, Gonzalo
    Rojas-Duran, Fausto
    Elena Hernandez-Aguilar, Maria
    Herrera-Covarrubias, Deissy
    Donaji Chi-Castaneda, Lizbeth
    Rebeca Toledo-Cardenas, Maria
    Manuel Suarez-Medellin, Jorge
    GERIATRICS, 2024, 9 (04)
  • [33] Pharmacological strategies for the prevention of Alzheimer's disease
    Doraiswamy, PM
    Xiong, G
    EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (01) : 1 - 10
  • [34] MicroRNAs as a New Target for Alzheimer's Disease Treatment
    Shademan, Behrouz
    Avci, Cigir Biray
    Karamad, Vahidreza
    Sogutlu, Fatma
    Nourazarian, Alireza
    MICRORNA, 2023, 12 (01) : 3 - 12
  • [35] Neuroprotection in alzheimer's disease - new strategies for treatment
    Nordberg, Agneta
    NEUROTOXICITY RESEARCH, 2000, 2 (2-3) : 157 - 165
  • [36] Treatment options in Alzheimer's disease -: What is evidence based?
    Weimer, E
    Frölich, L
    NERVENHEILKUNDE, 2005, 24 (02) : 120 - +
  • [37] Neuroprotection in alzheimer’s disease — new strategies for treatment
    Agneta Nordberg
    Neurotoxicity Research, 2000, 2 : 157 - 165
  • [38] Alzheimer's disease: Current treatment options and future developments
    Tiedeman, Melissa
    Kim, E. Cynthia
    Flurie, Rachel
    Korch-Black, Karen
    Brandt, Nicole J.
    FORMULARY, 2011, 46 (07) : 268 - +
  • [39] Pharmacological treatment in moderate-to-severe Alzheimer's disease
    Hsiung, Ging-Yuek Robin
    Feldman, Howard H.
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (15) : 2575 - 2582
  • [40] Pharmacological treatment of Alzheimer's disease in the population of Catalonia, Spain
    Obach, Merce
    Lopez, Pilar
    Catalan, Arantxa
    MEDICINA CLINICA, 2017, 149 (02): : 86 - 87
12345